Methods for inhibiting undesired angiogenesis in patients having tumors with thalidomide

作者: Robert D'Amato

DOI:

关键词: In patientMedicineThalidomideAngiogenesisPharmacology

摘要:

参考文章(312)
Lejeune Jp, Faure M, Gaucherand M, Thivolet J, [PMN leukocytes chemotaxis: inhibition by thalidomide (author's transl)]. Pathologie Biologie. ,vol. 29, pp. 601- ,(1981)
Olivier Chosidow, Martine Bagot, Jean-Paul Vernant, Jean-Claude Roujeau, Catherine Cordonnier, Mathieu Kuentz, Janine Wechsler, Chantal André, René Touraine, Jean Revuz, Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases. Journal of The American Academy of Dermatology. ,vol. 26, pp. 49- 55 ,(1992) , 10.1016/0190-9622(92)70005-Z
N D Heaton, A S Reece, K C Tan, Graft-versus-host disease following liver transplantation. Journal of the Royal Society of Medicine. ,vol. 85, pp. 313- 314 ,(1992)
Revuz J, Current use of thalidomide Annales De Dermatologie Et De Venereologie. ,vol. 117, pp. 313- 321 ,(1990)
P R Carroll, N Weidner, J Flax, W Blumenfeld, J Folkman, Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. American Journal of Pathology. ,vol. 143, pp. 401- 409 ,(1993)
Sari H Enschede, Melissa L Larson, Stephanie A Gregory, HIV-related lymphoma treated with maintenance thalidomide. Clinical advances in hematology & oncology. ,vol. 3, pp. 231- ,(2005)
Naafs B, Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage. International Journal of Leprosy and Other Mycobacterial Diseases. ,vol. 64, ,(1996)